Tsubota Laboratory Incorporated
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Tsubota Laboratory Incorporated made a loss over the last year. Tsubota Laboratory Incorporated owes ¥0.44 for every ¥1 it owns. Tsubota Laboratory Incorporated made a loss in the year to Mar 2026, after a profit the year before.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
LossTsubota Laboratory Incorporated made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
8.72The share price is 8.72 times Tsubota Laboratory Incorporated's book value per share, higher than 95% of Healthcare companies in Japan.
Market cap
¥6.4 BThe total market value of all of Tsubota Laboratory Incorporated's shares at today's price (share price × number of shares), smaller than 73% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥734 MWhat Tsubota Laboratory Incorporated would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥28.45Net worth divided by the number of shares. The share price of ¥248.00 is 8.7 times this, which is the P/B above.
Return on equity (ROE)
-65.3%Tsubota Laboratory Incorporated lost 65.3% of its shareholders' money over the last year, lower than 91% of Healthcare companies in Japan.
Owes vs Owns
0.44×Tsubota Laboratory Incorporated owes ¥0.44 for every ¥1 it owns (low), higher than 55% of Healthcare companies in Japan.
Dividend yield
NoneTsubota Laboratory Incorporated does not currently pay a dividend.
Revenue growth
-85%Revenue fell 85% in the year to Mar 2026, and shrank 41% a year on average over 3 years.
Profit growth
LossTsubota Laboratory Incorporated made a loss in the year to Mar 2026, after a profit the year before.
Profit margin
-380.9%Tsubota Laboratory Incorporated lost ¥381 for every ¥100 of revenue.
Interest cover
Not coveredTsubota Laboratory Incorporated's operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net cashTsubota Laboratory Incorporated held ¥901 M more cash than debt (net cash) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Tsubota Laboratory Incorporated: ¥6.4 B ÷ ¥734 M (30 Jun 2026) = 8.7.
What is Tsubota Laboratory Incorporated's return on equity?
Tsubota Laboratory Incorporated lost 65.3% of its shareholders' money over the last year, lower than 91% of Healthcare companies in Japan.
How much does Tsubota Laboratory Incorporated owe compared with what it owns?
Tsubota Laboratory Incorporated owes ¥0.44 for every ¥1 it owns (low), higher than 55% of Healthcare companies in Japan.
Does Tsubota Laboratory Incorporated pay a dividend?
No. Tsubota Laboratory Incorporated does not currently pay a dividend.
Is Tsubota Laboratory Incorporated's revenue growing?
Revenue fell 85% in the year to Mar 2026, and shrank 41% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.